An orally available Mpro inhibitor is effective against wild-type SARS-CoV-2 and variants including Omicron - Concepedia

Concepedia

Publication | Open Access

An orally available Mpro inhibitor is effective against wild-type SARS-CoV-2 and variants including Omicron

DOI Full Paper Access

98

Citations

36

References

2022

Year

Baoxue Quan, Huiping Shuai, Anjie Xia, Yuxin Hou, Rui Zeng, Xinlei Liu, Guifeng Lin, Jingxin Qiao, Wenpei Li, Falu Wang,

Nature Microbiology

MedicineImmunologyAntiviral Drug DevelopmentAntiviral TherapyVirologyPharmacotherapyAvailable Mpro InhibitorAntiviral DrugPharmacologyAntiviral CompoundNovel TherapyDrug DiscoveryCovid-19

References

	Year	Citations

Page 1

Page 1